WAKMAR2 and neoplasm: According to the finding, WAKMAR2 was acknowledged as a main candidate engaged in invasive breast cancer through modulating the tumor microenvironment and will possibly function by regulating immune-related target genes, including IL27RA, RAC2, FABP7, IGLV1-51, IGHA1, and IGHD.